News
The Ohio State University Commences Key Comparative Study of Vycor's Patented ViewSite Brain Access System
May 20, 2013 8:30 am | by The Associated Press | CommentsVycor Medical, Inc. ("Vycor") (OTCQB: VYCO), a medical device company with a suite of FDA approved products, announced today that the Minimally Invasive Cranial Surgery Program at the Ohio State University (Columbus, OH) has commenced an animal study to evaluate a comparison of tissue damage...
Intermountain Healthcare Partners With Sotera@ Wireless
May 20, 2013 8:01 am | by The Associated Press | CommentsSotera Wireless@, creator of the ViSi Mobile@ wireless patient monitoring system, announced today that Intermountain Healthcare will officially partner with the Company. Furthering this collaboration, Intermountain Healthcare executive vice president and chief financial officer Bert Zimmerli ...
GE Scientists in Technology “Relay Race” Against Cancer
May 20, 2013 8:00 am | by The Associated Press | CommentsNISKAYUNA, N.Y.--(BUSINESS WIRE)--May 20, 2013--To commemorate National Cancer Research Month, a team of scientists from GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are joined together in a technology “relay race” against cancer. They collectively are...
AB SCIEX Announces In Vitro Diagnostic Devices CE Marked for Europe
May 20, 2013 7:30 am | by The Associated Press | CommentsFRAMINGHAM, Mass.--(BUSINESS WIRE)--May 20, 2013--AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe. Meeting regulatory requirements to obtain the CE-IVDD mark for the new AB SCIEX API...
Medtronic Receives 'CE' Mark for 'Export Advance' Aspiration Catheter
May 20, 2013 7:06 am | by The Associated Press | CommentsExpanding its portfolio of medical technology for the interventional treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT) announced today that the Export Advance aspiration catheter recently received the CE (Conformité Européenne) mark and will soon be launched in Europe and other international markets.
OrbusNeich's GenousT Stent Associated With Lower Restenosis Rate Compared to Bare Metal Stents in Low-Risk Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Patients
May 20, 2013 5:00 am | by The Associated Press | CommentsOrbusNeich today announced that the company's Genous Stent is associated with a significantly lower rate of binary restenosis compared to bare metal stents (BMS) in low-risk non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients at six months. Data from JACK-EPC, an...
Class I Medical Device Recall: Abbott Diabetes Care, FreeStyle InsuLinx Blood Glucose Meters
May 20, 2013 12:00 am | by U.S. Food & Drug Administration | CommentsAt extremely high blood glucose levels of 1024 mg/dL and above, the FreeStyle InsuLinx Blood Glucose Meter will display and store in memory an incorrect test result that is 1024 mg/dL below the measured result. For example, at a blood glucose value of...
Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
May 19, 2013 1:43 pm | by Bio-Medicine.Org | CommentsSANTA ROSA, Calif. , May 20, 2013 /- Claret Medical, Inc. announced the publication of an original manuscript by Dr. Nicolas Van Mieghem et al., Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement . Published ahead of print in Circulation, May 7 th this research is the result of a collaboration between Erasmus Medical Center, Rotterdam,
Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy
May 19, 2013 8:24 am | by Bio-Medicine.Org | CommentsORLANDO, Fla. , May 19, 2013 /- The non-surgical Stretta® procedure employing low power and low temperature radiofrequency (RF) energy is effective in control of gastroesophageal reflux disease (GERD), and eliminates or reduces the need for medication 10 years post-procedure, according to an independent, prospective long-term assessment presented today at the Digestiv...
Statistical Challenges in Medical Device Trail Evaluation
May 17, 2013 4:30 pm | by The Associated Press | CommentsMedical devices are any medical items that are neither a drug nor a biological product. In light of their different mechanisms, actions and regulatory requirements, medical device (MD) trail evaluations are much more complicated than drug trails due to their unique clinical practices....
Wright Medical Hip Lawsuit Update: New Video Informs Patients Why Profemur Z Hip Implant Is Allegedly Failing
May 17, 2013 1:41 pm | by The Associated Press | CommentsSAN FRANCISCO--(BUSINESS WIRE)--May 17, 2013--Kent Klaudt, an injury lawyer at the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced that Lieff Cabraser released today a video on the injuries suffered by hip replacement patients who received the Profemur Z hip...
Blue Belt Technologies Announces Implant Co-Marketing Partnership with DJO Surgical
May 17, 2013 1:20 pm | by The Associated Press | CommentsPITTSBURGH--(BUSINESS WIRE)--May 17, 2013--Blue Belt Technologies, Inc., an innovative medical technology company commercializing robotic solutions for orthopedic surgery, announces an implant partnership with DJO Surgical, a DJO Global Company. Blue Belt’s NavioPFS orthopedic surgical system...
Security Risks Found in Sensors for Heart Devices
May 17, 2013 12:13 pm | by University of Michigan | CommentsThe type of sensors that pick up the rhythm of a beating heart in implanted cardiac defibrillators and pacemakers are vulnerable to tampering, according to a new study conducted in controlled laboratory conditions. Implantable defibrillators monitor the heart for irregular beating and, when necessary, administer an electric shock to bring it back into normal rhythm.
Nanotechnology Could Help Fight Diabetes
May 17, 2013 11:52 am | by Anne Trafton, MIT News Office | CommentsInjectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin. The nanoparticles were designed to sense glucose levels in the body and respond by secreting the appropriate amount of insulin, thereby replacing the function of pancreatic islet cells, which are destroyed in patients with Type 1 diabetes.
UT Arlington Physicist's Tool Has Potential for Brain Mapping
May 17, 2013 11:48 am | by University of Texas at Arlington | CommentsA new tool being developed by UT Arlington assistant professor of physics could help scientists map and track the interactions between neurons inside different areas of the brain. The journal Optics Letters recently published a paper by Samarendra Mohanty on the development of a fiber-optic, two-photon, optogenetic stimulator and its use on human cells in a laboratory.
